Other News

BONESUPPORT™ Announces First Patient Enrolled in FORTIFY Trial with CERAMENT®|G
Biologics Top Stories

BONESUPPORT™ Announces First Patient Enrolled in FORTIFY Trial with CERAMENT®|G

Lund, Sweden, 22 May 2017– BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone substitute products to treat bone voids caused by trauma, infection, disease or related surgery, today announced that the first patient has been enrolled by Dr Ravi Karia at the  University of Texas Health Science Center […]

3D Printed Medical Devices Market is projected to be valued at US$ 1469.4 million by the end of 2026
Financial

3D Printed Medical Devices Market is projected to be valued at US$ 1469.4 million by the end of 2026

NEW YORK, May 23, 2017 /PRNewswire/ — Highlights  ·         3D printed medical devices are state-of-the-art medical devices that involve a process of developing three dimensional solid objects from a digital model. ·         Patient specific treatment is the main advantage of 3D printing technology in the healthcare industry. ·         In the […]

United Orthopedic Corporation Announces First Patient Enrollment In Study Of U2 Knee™ System
Recon

United Orthopedic Corporation Announces First Patient Enrollment In Study Of U2 Knee™ System

IRVINE, Calif., May 23, 2017 /PRNewswire/ — United Orthopedic Corporation (UOC), a leading international designer, manufacturer and distributor of innovative orthopedic implants and instruments, today announced the launch of a primary total knee arthroplasty (TKA) trial. Entitled “Prospective Post Approval Clinical Follow-Up Study of the Commercially Available U2 Knee™ System – […]

Anika Announces Publication of Phase III Data Demonstrating the Efficacy and Safety of CINGAL®
Extremities

Anika Announces Publication of Phase III Data Demonstrating the Efficacy and Safety of CINGAL®

May 22, 2017 08:30 AM Eastern Daylight Time BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology, today announced the publication of Phase III data demonstrating the efficacy and safety of CINGAL®, its novel HA-corticosteroid […]

Anika Celebrates 25th Anniversary and Inaugurates Newly Expanded Global Manufacturing Facility
Biologics

Anika Celebrates 25th Anniversary and Inaugurates Newly Expanded Global Manufacturing Facility

May 23, 2017 08:30 AM Eastern Daylight Time BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology, is hosting a celebration today at its Bedford, Massachusetts headquarters to commemorate its 25th anniversary and inaugurate its […]

OrthoMemphis Performs First Meniscus Replacement in Tennessee with NUsurface® Implant
Sports Medicine

OrthoMemphis Performs First Meniscus Replacement in Tennessee with NUsurface® Implant

May 23, 2017 09:00 AM Eastern Daylight Time MEMPHIS, Tenn.–(BUSINESS WIRE)–OrthoMemphis and Active Implants, a Memphis-based company that develops orthopedic implant solutions, today announced that the first meniscus replacement procedure in Tennessee was successfully performed. Dr. Randall Holcomb, sports medicine orthopaedic surgeon and president of OrthoMemphis, was the surgeon selected […]

CollPlant Signs New Exclusive Distribution Agreement in Turkey for Vergenix®FG Wound Treatment
Biologics Top Stories

CollPlant Signs New Exclusive Distribution Agreement in Turkey for Vergenix®FG Wound Treatment

NES ZIONA, Israel, May 22, 2017 /PRNewswire/ — CollPlant (TASE: CLPT), a regenerative medicine company utilizing its proprietary plant-based rhCollagen (recombinant human “rhCollagen”) technology for tissue repair products announced that the Company has signed a new, exclusive distributor agreement in Turkey to market Vergenix®FG, for the treatment of chronic wounds. […]

Organogenesis Closes on a $20 Million Facility from Eastward Capital Partners
Biologics Financial Top Stories

Organogenesis Closes on a $20 Million Facility from Eastward Capital Partners

CANTON, Mass., May 22, 2017 /PRNewswire/ — Organogenesis Inc., a commercial leader in the field of regenerative medicine focusing on advanced wound care and surgical biologics, today closed a $20 million financing facility with Eastward Capital Partners, a leading provider of venture debt and equity financing to technology companies. “We were […]

NuVasive Announces Educational Initiatives In Support Of Spine’s Fastest Growing Spinal Deformity Portfolio
Spine Top Stories

NuVasive Announces Educational Initiatives In Support Of Spine’s Fastest Growing Spinal Deformity Portfolio

SAN DIEGO, May 22, 2017 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the Company’s increased investment and support of adult and pediatric deformity research, education, and awareness initiatives throughout 2017. NuVasive increased its focus on […]

Florida Institute Funds Alachua-based Amend Surgical
Biologics Financial Top Stories

Florida Institute Funds Alachua-based Amend Surgical

GAINESVILLE, Fla. and BOCA RATON, Fla., May 18, 2017 /PRNewswire-USNewswire/ — The Florida Institute for the Commercialization of Public Research (the Florida Institute) announced today that it has finalized a funding agreement with Amend Surgical, an Alachua-based medical device company with newly licensed technology developed at the University of Florida. The Florida […]

Forbes Names The DeAngelis Group Among the Top 250 Best Executive Recruiting Firms in 2017
Recon Spine

Forbes Names The DeAngelis Group Among the Top 250 Best Executive Recruiting Firms in 2017

SCOTTSDALE, ARIZONA (PRWEB) MAY 19, 2017 The De Angelis Group, the largest search firm dedicated solely to the orthopedic industry was named amongst the top 250 “Best Executive Recruiting Firms” listed by Forbes for 2017. The recent article was published on http://www.forbes.com on May 3, 2017, written by Jeff Kauflin. Forbes […]